Author/Authors :
Al Raddadi, Ali A. National Guard Hospital, King Abdulaziz Medical City - Dermatology Division, Saudi Arabia , Fatani, Mohammad I. Hera General Hospital, Saudi Arabia , Shaikh, Yasir H. King Fahd Specialist Hospital, Saudi Arabia , Thaci, Diamant Goethe University, Germany , Al Reshaid, Abdullah A. National Guard Hospital, King Abdulaziz City, Saudi Arabia , Al-Eisa, Abdullah M. Derma Clinic, Saudi Arabia , Alghamdi, Walid A. Security Force Hospital, Saudi Arabia , Abdulfattah, Hassan Y. Riyadh Medical Complex, Saudi Arabia , Al Belbisi, Zohir M. Riyadh Medical Complex, Saudi Arabia , Atawi, Ali C. Specialized Medical Center, Saudi Arabia , Alajroush, Waleed A. National Guard Hospital, King Abdulaziz City, Saudi Arabia , Al Fadly, Abdullah A. King Faisal Specialist Hospital and Research Center, Saudi Arabia , El-Shamy, Said I. National Hospital, Saudi Arabia , Zimmo, Sameer K. King Abdulaziz University, Saudi Arabia , Alqahtani, Abdullah A. Military Hospital, Saudi Arabia , Abdulghani, Majdy M. King Fahd Military Hospital, Saudi Arabia , Al Abod, Khaled M. King Faisal Hospital, Saudi Arabia , Al Attas, Khaled M. King Fahd Central Hospital, Saudi Arabia , Al Ayouby, Mohamad F. King Fahd Hospital, Saudi Arabia , Qari, Mohammed S. King Abdulaziz University, Saudi Arabia , Al Ghanim, Adel S. King Fahd Military Medical Complex, Saudi Arabia
Abstract :
Psoriasis is a chronic, noncontiguous, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. There is a genetic predisposition to psoriasis and has tendency to wax and wane with flares related to systemic or environmental factors, including life stress events and infection. Majority of patients with psoriasis have limited disease (5% body surface area involvement) and can be treated with topical agents, which generally provide a high efficacy-to-safety ratio. To optimize the topical treatment of psoriasis in Saudi Arabia, the Saudi Society of Dermatology and Dermatologic surgery (SSDDS) have initiated a project to develop guidelines for the management of psoriasis. The guidelines are based on German and American one with subsequent discussion with experts in the field; they have been approved by a team of dermatology experts.
